UNITED STATES
SECURITIES & EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-C
REPORT BY ISSUER OF SECURITIES QUOTED ON NASDAQ
INTERDEALER QUOTATION SYSTEM
Filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
and Rule 13a-17 or 15d-17 thereunder
MICRO BIO-MEDICS, INC.
------------------------------------------------------------------------------
(Exact name of issuer as specified in charter)
846 Pelham Parkway, New York, NY 10803
--------------------------------------------------------------------------
(Address of principal executive offices)
Issuer's telephone number, including area code 914 738-8400
--------- --------------------
I. CHANGE IN NUMBER OF SHARES OUTSTANDING
Indicate any change (increase or decrease) of 5% or more in the number of
shares outstanding
1. Title of security Common Stock
-------------------------------------------------------
2. Number of shares outstanding before the change 4,176,473
--------------------------
3. Number of shares outstanding after the change 5,019,219
---------------------------
4. Effective date of change Not applicable.
------------------------------------------------
5. Method of change:
Specify method (such as merger, acquisition, exchange, distribution,
stock split, reverse split, acquisition of stock for treasury, etc.)
Give brief description of transaction Exercise of public warrants
---------------------------------
which expired June 19, 1996.
----------------------------------------
- --------------------------------------------------------------------------------
II. CHANGE IN NAME OF ISSUER
1. Name prior to change
----------------------------------------------------
2. Name after change
-------------------------------------------------------
3. Effective date of charter amendment changing name
-----------------------
4. Date of shareholder approval of change, if required
---------------------
Date July 2, 1996
---------------------------- ----------------------------------
(Officer's signature & title)
BRUCE J. HABER, President,
Chief Executive Officer
